RARA CRAFT DATABASE for FDA Medical Devices
510(k)K250685

FDA DEVICE FACTS

Methinks NCCT Stroke

Methinks Software, S.L

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/ML
DECISION DATEJune 16, 2025PRODUCT CODEQASCLINICAL AREARadiology

Indications for use

Methinks NCCT Stroke is radiological computer-aided triage and notification software indicated for use in the analysis of non-contrast head CT (NCCT) images. The device is intended to assist hospital networks and trained physicians in workflow triage by flagging and communicating suspected positive findings of intracranial hemorrhage (ICH) and large vessel occlusion (LVO) of the ICA, MCA-M1, and MCA-M2. Methinks NCCT Stroke uses an artificial-intelligence algorithm to analyze images and highlight cases with suspected ICH and LVO in the cloud in parallel to the ongoing standard-of-care image interpretation. The user is presented with notifications for cases with suspected ICH or LVO findings via PACS and/or notifications. Notifications include preview images that are meant for informational purposes only and are not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a primary diagnostic device. Results are intended to be used in conjunction with other patient information and professional judgment to assist with triage and prioritization of medical images. Notified clinicians are ultimately responsible for reviewing full images per the standard of care. Methinks NCCT Stroke is for adults only. All patients should receive adequate care for their symptoms, including CTA and/or other appropriate care per standard clinical practice, irrespective of device output. The device is not intended to be a rule-out device; cases processed without an "LVO Suspected" notification should not be viewed as indicating that LVO is excluded. All cases should undergo CTA per the standard stroke workup. The device does not replace the need for CTA in ischemic-stroke workup; it provides workflow prioritization and notification only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026